EP2245157A1 - Procédé pour l'extraction et la purification d'acides nucléiques sur une membrane - Google Patents

Procédé pour l'extraction et la purification d'acides nucléiques sur une membrane

Info

Publication number
EP2245157A1
EP2245157A1 EP09703892A EP09703892A EP2245157A1 EP 2245157 A1 EP2245157 A1 EP 2245157A1 EP 09703892 A EP09703892 A EP 09703892A EP 09703892 A EP09703892 A EP 09703892A EP 2245157 A1 EP2245157 A1 EP 2245157A1
Authority
EP
European Patent Office
Prior art keywords
membrane
nucleic acids
detection
cells
microorganisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09703892A
Other languages
German (de)
English (en)
Inventor
Roxana Isac
Frédéric Marc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMD Millipore Corp
Original Assignee
Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millipore Corp filed Critical Millipore Corp
Publication of EP2245157A1 publication Critical patent/EP2245157A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes

Definitions

  • the present invention relates to a method for the extraction of nucleic acids which can be applied to a very small number of microorganisms filtered on a membrane, using a lysis composition comprising the combination of a guanidium salt and N-Lauroyl-sarcosine (NLS).
  • a lysis composition comprising the combination of a guanidium salt and N-Lauroyl-sarcosine (NLS).
  • This method makes it possible to collect the nucleic acids of said microorganisms in a form suitable for detection in a specific manner by hybridization or amplification.
  • microbiological quality control of water and air, as well as tools and materials used or rejected is required to comply with increasingly strict standards.
  • the industrial players and health authorities need to have tools at their disposal capable of detecting microbiological contamination as quickly as possible, so that remedial measures can be taken expeditiously and at a reduced cost.
  • microbiological monitoring is carried out on a agar culture medium.
  • This type of culture which is simple to implement, allows a germ enumeration to be carried out with the naked eye. It also makes it possible for the living microorganisms to be preserved, and if necessary for characterization terms to be earned out with the aim of defining the genus or the species of the different germs present.
  • characterization tests generally consist of extracting the nucleic acids contained in the microorganisms and amplifying said nucleic acids in a specific manner, by one of a number of chain reaction techniques (PCR: polymerization chain reaction or LCR: ligature chain reaction) known to a person skilled in the art.
  • PCR polymerization chain reaction
  • LCR ligature chain reaction
  • characterization tests by amplification of nucleic acids have a high level of reliability
  • the steps consisting of culturing the microorganisms, extracting their nucleic acids, and implementing the PCR technique take a long time to perform.
  • the microorganisms In order to be visible to the naked eye, the microorganisms must be cultured for at least 24 hours, and sometimes longer, for slower-growing microorganisms such as methylobacterium sp. or because the germs have been stressed by the environmental conditions.
  • the extraction of nucleic acids cannot be carried out directly on the gelose, which means that the microorganisms must be removed before their nucleic acids are extracted. In this case, the detection becomes qualitative and is no longer quantitative.
  • This method is described in Application WO 92-00145. It consists in that the microorganisms contained in a solution or in the air are retained at the surface of a membrane by passing the liquid or the air through the latter. The microorganisms are cultured at the surface of the membrane in contact with a agar culture medium for the time necessary to form a microcolony which is invisible to the naked eye. The cells forming the microcolony are then lysed in order to release their adenosine triphosphate (ATP) content. The ATP released is used as a marker in order to identify and quantify the living cells by ATP-bioluminescence.
  • ATP adenosine triphosphate
  • the ATP serves as a substrate to an enzyme producing a chemiluminescence reaction by which a light signal is obtained, then detected using an appropriate video interface (eg: LCD camera).
  • a video interface eg: LCD camera.
  • the signal obtained, formed into an image makes it possible to visualize in-situ the place on the membrane where the germ is developing, in a manner analogous with a standard counting method carried out on a Petri dish in a agar medium.
  • This interface also makes it possible to quantify the number of microorganisms initially present in the liquid or gaseous sample analysed. Detection of microorganisms in the Milliflex ® system is called
  • ATP adenosine triphosphate
  • This technology makes it possible to detect the presence of contaminants quickly, whatever the microorganisms concerned, even at very low concentrations, for example on an industrial production line or in a clean room, so that the necessary decontamination measures can be taken within a short timescale.
  • the main obstacle to this identification resides in the fact that the detection by ATP-bioluminescence implemented in the Milliflex ® , system is destructive of the microorganisms involved. Indeed, during the reaction for detection by bioluminescence, the microorganisms are treated firstly, using an ethanol-based solution in order to extract the ATP molecules, then secondly by bioluminescence reagents.
  • the membrane is dried between these two steps in order to carry out the bioluminescence reaction.
  • the result of these treatments is that the microorganisms are killed, which prevents their subsequent culture for carrying out standard characterization tests (antibiotic resistance, metabolic markers, gram reactions, etc.).
  • the inventors have therefore undertaken, according to the present invention, to characterize the microorganisms detected by retrieving the nucleic acids of the microorganisms treated by bioluminescence in order to proceed to their specific detection by hybridization or by amplification, in particular by PCR.
  • the techniques of amplification or hybridization of the nucleic acids require purified samples of DNA or RNA which are sufficiently concentrated to make it possible to proceed reliably to the desired detection reactions.
  • the difficulties in retrieving these nucleic acids are numerous, in particular due to the fact that:
  • the microorganisms are dispersed at the surface of the membrane in the form of one or more micro-colonies, each one of which comprises a small number of microorganisms, generally less than 10 3 cells; and that
  • the cells containing the nucleic acids to be extracted are dried, and moreover have been previously treated with agents and salts capable of inhibiting or reducing the yield of the hybridization or the PCR reactions.
  • nucleic acids must be recovered in solution on the membrane, purified and concentrated.
  • nucleic acids contained in cells which differ according to the nature, RNA or DNA, of the nucleic acids.
  • lysis buffer a step of precipitation of the nucleic acids in solution.
  • the purpose of the lysis buffer is to rupture the cell membranes and solubilize the proteins, while the precipitation makes it possible to separate the nucleic acids from the other cell constituents in solution.
  • RNA more fragile than DNA
  • phenol-chloroform the most usual method for extracting the RNA (more fragile than DNA) is for example, the one known as the "phenol-chloroform" method.
  • the cells are firstly placed in contact with a lysis buffer comprising a detergent-proteinase K mixture, the purpose of which is to dissociate the cell constituents and release the nucleic acids.
  • the lysis buffer used generally comprises as a detergent, dodecyl sodium sulphate (SDS) 1 which is the cell lysis agent, as well as an activator of proteinase K such as sarkosyl, Tween ® 20, or Nonidet P40.
  • SDS dodecyl sodium sulphate
  • the nucleic acids contained in the cell lysate obtained are then separated from the proteins, by applying a mixture of phenol, a powerful deproteinizing agent, and chloroform, which is an organic solvent. After centrifugation, the nucleic acids are solubilized in the organic phase, while the proteins are collected at the interphase between the aqueous phase and the organic phase.
  • the nucleic acids are treated with an chloroform-isoamylic alcohol mixture.
  • the effect of this is to eliminate the traces of phenol, an organic compound which has the drawback of being not only a toxic product but also an inhibitor of certain enzymes, including polymerase.
  • the nucleic acids are then precipitated by the addition of a precipitation agent, typically absolute ethanol at -20 0 C, at the rate of 2.5 times the volume of the lysis buffer, or the isopropanol, at the rate of 0.7 volume.
  • a precipitation agent typically absolute ethanol at -20 0 C
  • a subsequent washing of the precipitated nucleic acids in 70% ethanol is indispensable for removing the salts.
  • the precipitate is then taken up in a buffer with a low ionic strength, in general, a Tris-EDTA buffer (10/1 mM).
  • Phenol/chloroform method is the reference method in respect of nucleic acid extraction, the latter has the drawback of comprising a number of steps and using phenol and chloroform, which are both volatile and toxic products which must be handled with care.
  • a lysis buffer typically comprising between 4 and 6 M guanidium thiocyanate, 10 mM EDTA, between 2 and 6% NLS and 50 mM Tris-HCI (neutral pH) (so-called modified Crude Susan method) [Chirgwin, J. et al.
  • micro-columns containing silica beads, or a similar solid adsorption phase in order to facilitate the steps of washing and recovery of the nucleic acids.
  • the principle is the same, since a step of precipitation of the nucleic acids on the adsorption phase is also required.
  • the purpose of the present invention is therefore to achieve a simple, rapid and effective method for preparing nucleic acids, both DNA and RNA, from a small number of microorganisms, in order to then carry out their characterization.
  • the present Application discloses a method for the extraction and purification of genomic DNA which can be applied, for example, to cells filtered on a membrane, by which the cells are treated in solution using guanidium chloride and a limited quantity of NLS.
  • the nucleic acids are purified on a membrane, without continuing to a precipitation step, and the DNA retained by the membrane is recovered in a volume of pure or buffered water in a form suitable for detection by hybridization or by PCR.
  • the best detection results were obtained by the inventors using a low concentration of NLS in the composition, much lower than that usually found in lysis compositions. It has been noted in particular that at this low concentration, the NLS made it possible to avoid the problems associated with clogging the membrane during the purification step, and also to facilitate the retrieval of nucleic acids at the end of the method.
  • the invention was implemented more particularly with the aim of characterizing, by PCR, a very small number of microorganisms filtered on a membrane, up to the detection threshold of 1 CFU of the Milliflex ® Rapid system.
  • the invention can be applied outside the particular context of membrane microbiology, whatever the type of cells involved, for preparing nucleic acids, in particular with the aim of carrying out hybridization or amplification reactions.
  • the nucleic acid preparations obtained can be used, for example, to carry out PCR reactions or isothermal amplification reactions of the LAMP type, or also reactions involving RNA molecules, such as amplification of the NASBA or TMA type, it being understood that the RNA sequences can be transcribed to DNA by a retro-transcription step.
  • FIG. 1 Comparison of the effectiveness of lysis compositions 1 to 7 used for the detection of microorganisms by PCR.
  • the DNA has been purified on a cellulose membrane contained in a (Microcon ® ) centrifuge tube following treatment of the cells by the corresponding lysis composition.
  • the experiment was carried out on fresh cells sampled on a culture (cells in suspension), fresh cells sampled on a PVDF filtration membrane or on cells sampled on a PVDF membrane after treatment with ATP-bioluminescence (according to the Milliflex ® Rapid method).
  • pure DNA was introduced into the lysis compositions, then purified on a membrane, as in the case of the other preparations.
  • the compositions were tested at least twice per experiment.
  • the cells detected are E. coli bacteria.
  • the PCR results are given in the form of photos showing the reproducibility and intensity of the amplification. +: positive amplification; -: negative amplification, ⁇ A: absence of reproducibility; ND: not performed; NA: negative result on membrane.
  • Figure 2 Test results of the nucleic acid extraction and detection method according to the invention, as it relates to C. albicans and S. cerevisiae yeasts.
  • the agarose gels show a good reproducibility of the amplifications by PCR.
  • the wells are numbered from left to right: 1 : positive PCR control (pure DNA of C.
  • PCR reactions are carried out with universal primers, making it possible to detect unicellular fungi. In the centre the synthesis images of the membrane are shown resulting from the universal detection by ATP-bioluminescence carried out for each PCR-tested sample.
  • Figure 3 Test results of the nucleic acid extraction and detection method according to the invention, as it relates to the genomic DNA (A) of the gram-positive bacteria S. aureus, S. epidermidis, B. subtilis (B) the gram- negative bacteria P. aeruginosa, E. coli, S. enterica.
  • the wells of the agarose gels are numbered from left to right. 1 : positive PCR control; 2 to 4: PCR carried out for 3 independent samples with primers common to gram-positive or gram-negative bacteria; 5: 100 pb plus ladder.
  • the synthesis images of the membrane are shown resulting from the universal detection by ATP-bioluminescence carried out for each PCR-tested sample.
  • Figure 4 Test results of the nucleic acid extraction and detection method according to the invention, as it relates to the genomic DNA of populations of cells comprising a mixture of E. coli and S. epidermis.
  • A enumeration of the mixture of the cells in three populations by ATP- bioluminescence following the Milliflex ® method.
  • B detection by PCR amplification according to the invention, visualized on agarose gel.
  • 1 PCR positive control
  • 2 to 4 PCR carried out for each of the three populations
  • 5 negative control
  • 6 100 pb plus ladder.
  • 1 st series PCR carried out using universal primers on E.coli and S.epidermis
  • 2 nd series PCR carried out with specific primers on E. coli
  • 3 rd series PCR carried out with specific primers on S.epidermis
  • 4 th series P CR carried out with specific primers on B. subtilis.
  • Figure 5 Detection by ATP-bioluminescence (Milliflex Rapid ® ) then by PCR and micro-sequencing according to the invention.
  • A count of 13 CFU of S. epidermidis and 9 CFU of B. subtilis.
  • B visualization on gel of the products of PCR amplification carried out on the extracts of genomic DNA purified from the same cells of S. epidermis and S. subtilis as those detected on the membrane in A.
  • C Results of the micro-sequencing carried out on the amplification products visualized in B.
  • Figure 6 Results of the sensitivity tests relating to PCR detection of the unicellular fungi and bacteria according to the invention.
  • the genomic DNA corresponding to 1 CFU, detected firstly by bioluminescence, is extracted then detected by PCR according to the method of the invention.
  • B Positive results of PCR obtained for 3 different samples of unicellular fungi (S. cerevisiae)
  • Figure 7 Detection by ATP bioluminescence and PCR of the gram- positive bacteria P. acnes.
  • Figure 8 Real-time accumulation profile of the RNA amplification fragments resulting from the amplification by TMA of RNA contained in two nucleic acid preparations extracted from Pseudomonas aeruginosa according to the invention.
  • the preparations correspond respectively to a number of bacteria of approximately 30 and 300 CFU.
  • the subject of present invention is thus a method for the extraction and detection of nucleic acids on membrane, making it possible to identify the microorganisms present in a low concentration in a liquid or gaseous medium, or even present on a surface.
  • the method according to the invention relates more particularly to the detection of microorganisms transferred onto a membrane by filtration of a liquid or gaseous sample through the latter, or by placing said membrane in contact with a medium or a surface capable of containing or comprising microorganisms. It aims more particularly at solving the problem of identification of germs dispersed at the surface of the membrane.
  • the method according to the invention is particularly appropriate for the identification of microorganisms previously detected on a membrane, for example using a non-specific method such as ATP bioluminescence used in the Milliflex rapid method.
  • the method according to the invention consists of extracting and purifying the nucleic acids of a small number of cells, living or dead.
  • RNA and/or DNA nucleic acids can be applied, outside the particular context of the detection of microorganisms on a membrane, to any cell from which it is sought to extract nucleic acids in a rapid and effective manner.
  • This method is particularly useful in order to obtain RNA and/or DNA nucleic acids, in a form suitable for producing the hybridization or amplification reactions necessary for their characterization.
  • This method comprises the following steps, during which: a) cells are treated with guanidium chloride and N-Lauroyl- sarcosine (NLS) in solution, in order to lyse the cells and release the nucleic acids that they contain; b) the nucleic acids are separated from the cell lysate obtained by the filtration of said lysate through a membrane; c) the nucleic acids retained by said membrane are recovered in solution in water or a weakly ionized aqueous solution.
  • a "cell” is defined herein as a biological entity of small size comprising a cytoplasm delimited by a membrane and containing genetic material in the form of nucleic acids.
  • microorganism within the meaning of the present invention, a cell having a microscopic size, i.e. a size comprised between 0.5 and 5 microns, having a metabolic and reproductive potential, such as algae, unicellular fungi, protozoans, mycetes, bacteria or also gametes.
  • the microorganisms sought are more particularly pathogenic bacteria gram-positive or gram-negative bacteria of the genera Pseudomonas, Escherichia, Legionella, Salmonella, Listeria, Bacillus, Streptococcus, Vibrio, Yersinia, Staphylococcus, Mycobacterium, Shigella, Clostridium, Campylobacter, or Aeromonas; protozoans of the genera Giardia, Entamoeba, Cryptosporidium, Cyclospora; mycoplasms of the genera Mycoplasma and Ureaplasma, fungi of the genera Saccharomyces, Aspergillus, Candida or
  • Lauroyl-sarcosine can be carried out, by one and then the other of these compounds or even simultaneously.
  • the treatment is carried out using a lysis composition comprising an
  • NLS concentration comprised between 0.1 and 1% of the total weight of the composition.
  • the guanidium chloride is a chaotropic agent which is used as a lysis agent. It has the double effect of denaturing the proteins, in particular the membrane proteins, and producing osmotic shock. It is generally used at a concentration comprised between 3 and 8 moles per litre, more preferably between 4 and 6 moles per litre of lysis composition.
  • N-Lauroyl-sarcosine (Sarkosyl NL-97 or NLS) is a sodium salt of N- methyl-N-(1-oxododecyl)glycine (Ci 5 H 2S NO 3 Na). This molecule is a detergent often used in lysis buffers in combination with proteinase K, at concentrations of the order of several moles per litre, for solubilizing the proteins, in particular the membrane proteins.
  • NLS is not used as a lysis agent or at least not principally.
  • NLS is preferably used at a concentration comprised between 0.1 and 1% of the final weight of the lysis composition, more preferably between 0.1 and 0.5%, i.e. at a concentration where the effect on cell lysis is limited.
  • NLS is an anionic detergent which denatures almost all the non- covalent interactions in the proteins and tends to solubilize the proteins.
  • NLS facilitates the separation of the DNA and the proteins during filtration of the cell lysate through the membrane, and the rinsing of the DNA which follows.
  • the lysis composition according to the invention also comprises between 0.1 and 1 mmol.l “1 of ethylenediaminetetraacetic acid (EDTA).
  • EDTA ethylenediaminetetraacetic acid
  • the presence of EDTA makes it possible to improve the lysis of not only gram- negative, but also gram-positive microorganisms. In principle, EDTA makes it possible to destabilize the membrane of bacteria by sequestering the divalent ions.
  • membrane denotes a synthetic support having two surfaces, the pores of which have a known average diameter. Such a membrane has a high surface/volume ratio. The thickness of the membrane is generally constant, between 90 and 200 microns.
  • Such a membrane can be single- or multi-layer. It is generally constituted of one or more materials chosen from polytetrafluoroethylene, polyvinylidene fluoride (PVDF), polycarbonate, polyamide, polyester, polyethersulphone, acetylcellulose and nitrocellulose.
  • PVDF polyvinylidene fluoride
  • the membrane designated in step b) of the DNA extraction method according to the invention is generally a membrane made of cellulose called an ultrafiltration membrane i.e. a membrane which has a molecular weight nominal limit between 3'00O and 100,000 daltons, preferably between 50,000 and 100,000 daltons.
  • an ultrafiltration membrane i.e. a membrane which has a molecular weight nominal limit between 3'00O and 100,000 daltons, preferably between 50,000 and 100,000 daltons.
  • An example of this type of membrane is the one with which microcon ® centrifuge tubes (Millipore Corporation) are provided.
  • separation of the nucleic acids from the cell lysate is carried out through the membrane, under the effect of a negative or positive pressure.
  • passage of the lysate can be carried out by means of a low pressure on one of the surfaces of the membrane, using a vacuum pump.
  • This can also activated under the effect of centrifugation, i.e. by applying a centrifugal force to the cell lysate at the surface of the membrane.
  • the centrifugation effect is generally obtained by placing the membrane on a support such as a centrifuge tube, placed in a centrifuge.
  • the invention moreover provides that between steps b) and c) of the method, a step of washing the nucleic acids retained by the membrane can be carried out, using a washing solution such as water or a weakly ionized aqueous solution.
  • a washing solution such as water or a weakly ionized aqueous solution.
  • the washing solution is removed after passing through the membrane.
  • step c) the nucleic acids can be easily recovered by passing the water or the weakly ionized aqueous solution through the membrane, in the opposite direction to that applied in step b) or even that of the additional washing step mentioned above.
  • step c) is facilitated by the application of a negative or positive pressure, or even by centrifugation, all that is required is to place the support on which the membrane is fixed in the opposite direction to its original one, and place a drop of the weakly ionized solution on the surface of the membrane.
  • the force exerted by the pressure or the centrifugation forces the water through the membrane pores and releases the nucleic acids from the membrane.
  • the nucleic acids are then collected in the drop of water thrown to the bottom of the centrifuge tube.
  • the invention relates to a method for the detection of one or more cells in a liquid or gaseous medium, characterized in that it comprises the following steps: a) a sample of the liquid or gaseous medium is filtered through a membrane in order to retain the cells contained in said sample on said membrane; b) the cells retained in step a) are treated with guanidium chloride and N-Lauroyl-sarcosine (NLS) in solution, in order to obtain a cell lysate containing the nucleic acids released from said cells; c) the nucleic acids of the cell lysate obtained in step b) are separated by filtration of said lysate through said membrane, or through another membrane; d) the nucleic acids retained by the membrane in step c) are recovered in water or in an weakly ionized aqueous solution; e) the nucleic acids recovered in step d) are detected.
  • NLS N-Lauroyl-sarcosine
  • Steps b) to d) of said detection method preferably correspond to the method for the extraction and purification of nucleic acids according to the invention, i.e. those carried out according to steps a) to c) of the method described above.
  • the purpose of the detection method is to count the cells, more particularly the microorganisms present in a liquid medium such as water, or gaseous medium such as air, while determining their identity as far as possible, (family, genus, species, etc.).
  • Liquid or gaseous medium denotes any fluid capable of being filtered by applying a pressure difference across a membrane having pores of a an average diameter generally comprised between 0.1 and 1.5 microns, preferably between 0.15 and 0.8 microns, more preferably between 0.2 and 0.6 microns.
  • Such a fluid can consist of pure solutions forming part of the manufacture of sterile products but also complex solutions (potable water, serum, urines, amniotic fluid, etc.) or also gaseous mixtures such as atmospheric air.
  • step a) of the detection method cell transfer is generally carried out on a so-called filtration membrane, i.e. a membrane which is permeable to liquid or gaseous media, the average pore size of which, however, allows the retention of at least 80%, preferably 90% of the cells or microorganisms sought.
  • this membrane is mainly constituted of PVDF (polyvinylidene fluoride), cellulose or polyethylenesulphone. More preferably, it is a filter membrane made of PVDF, of the type sold by the firm Millipore under the trade name Milliflex and the references MXHVWP124 or RMHVMFX24.
  • the membrane used for separating the nucleic acids of the lysis composition in step c) is different from that used in step a).
  • the membrane used in step a) can moreover be placed in contact with a nutrient medium so that the cells or microorganisms retained by said membrane can grow on its surface between steps a) and b).
  • the nutrient medium is then generally a gelose medium, the nutrients of which reach the cells by capillary action. While multiplying on the surface of the membrane, formation of the cells into micro-colonies takes place.
  • a detection step making it possible to count the microorganisms on the membrane, can be previously implemented before cell lysis in step b), for example, by extracting the ATP from the cells between step a) and step b), and by reacting this ATP with a bioluminescent reagent comprising luciferine and luciferase.
  • the nucleic acids extracted are constituted by RNA and DNA, in particular messenger and ribosomal RNA and genomic
  • the method according to the invention has the advantage of being able to use RNA as well as DNA extracted from the cells by the method according to the invention.
  • Detection of the nucleic acids in step e) is preferably carried out by a specific hybridization of all or part of the nucleic acids recovered in step d) using a primer or a probe capable of being specifically marked.
  • probe macromolecules capable of recognizing and combining with one of the categories of nucleic acids mentioned above, making their marking possible.
  • primer macromolecules capable of recognizing and combining with one of the categories of nucleic acids mentioned above, in order to initiate amplification reactions of said nucleic acids.
  • the probe or the primer used is generally a macromolecule capable of hybridizing with the DNA or RNA sequences present among the extracted nucleic acids with a certain degree of specificity.
  • the invention envisages any type of probe or primers known to a person skilled in the art which can give rise to a specific hybridization with nucleic acids such as for example simple oligonucleotides, oligonucleotides of the 2'0-methyl-RNA type, probes or primers of the PNA type (probes constituted by a polypeptide chain substituted by purine and pyrimidine bases) [Nielsen P.E. et al.
  • LNA oligonucleotides comprising one or more monomers of 2'-O-4'- C-methylene- ⁇ -D-ribofuranosyl
  • amplification reaction By amplification reaction is designated the enzymatic reactions making it possible to synthesize from said nucleic acids, macromolecules the presence of which can be detected by standard methods, for example by chromatography on agarose gel or acrylamide, micro-sequencing or fluorescence.
  • the method according to the invention can therefore comprise in step e) a step of amplification of all or part of the nucleic acids recovered in step d) by one of the techniques known to a person skilled in the art such as PCR
  • Such an amplification can prove useful for the optimum detection of microorganisms by increasing the quantity of the nucleic acids available for the purposes of detection. If this step of amplification is highly specific, it moreover makes it possible to identify the microorganisms with greater selectivity.
  • the nucleic acid preparations obtained according to the method of the invention are particularly suitable for the implementation of a detection of nucleic acids by amplification.
  • a subject of the invention is also a kit for the extraction of nucleic acids, characterized in that it comprises: a membrane, preferably made of cellulose or PVDF. a lysis composition as defined previously.
  • this kit moreover comprises one or more specific probes or primers for carrying out the detection of the nucleic acid extracted, in particular by hybridization or by PCR.
  • this kit can also comprise a second membrane for the filtration of a liquid or gaseous medium. This kit makes it possible for the method according to the invention to be implemented.
  • kit is particularly useful for implementing the methods for extraction and purification of DNA, and subsequently, for identifying the cells or microorganisms under the conditions defined previously.
  • microorganisms used in the detection test described hereafter were obtained from the American microorganism collection ATCC.
  • the reference number of the strains is given in Table 1.
  • strains were kept at -80 0 C in a suitable medium (Sigma, ref C6039). They were then cultured and diluted in a peptone-based medium (Biomerieux, ref. 42111 ) in order to obtain the required density.
  • Petri dishes containing a gelose medium inoculated with 100 ⁇ l of a diluted culture are incubated for 24 to 48 hours at 35°+/-2.5°C for bacteria, 48 to 72h at 25°+/-2.5°C for the yeasts and the moulds.
  • the colonies are visually enumerated on three different dishes in order to determiner the concentration of the diluted cultures which were used for their inoculation
  • the apparatus and consumables associated with the Milliflex ® system sold by Millipore were used for filtering the same 100 ⁇ l of diluted culture on a membrane made of cellulose (MCE) (Millipore, ref. MXHAWG124) or of polyvinylidene fluoride (PVDF) (Millipore, ref. RMHVWP124), the average pore diameter of which is 0.45 ⁇ m.
  • MCE cellulose
  • PVDF polyvinylidene fluoride
  • filtration is carried out using a vacuum pump through the cellulose membrane and the membrane is transferred onto a gelose medium cassette;
  • microorganisms are allowed to develop on the membrane, either for a few hours for counting by ATP bioluminescence (rapid microbiology) or for 1 or 2 days for counting with the naked eye.
  • the automated rapid detection system (Milliflex Rapid Microbiology
  • Detection system is then used for detecting the microcolonies which develop on the PVDF membrane, using the ATP bioluminescence technique.
  • This technique uses a lysis reagent to release the ATP of the cells and a bioluminescence reagent comprising luciferase and luciferine using the ATP as a reaction substrate.
  • the membranes are treated by spraying 35 ⁇ l of each of the reagents by using a suitable spray (Milliflex Rapid Autospray Station; Millipore, ref. MXRP SPRKT).
  • the photons produced by the reaction between the ATP and the bioluminescence reagent are detected in a darkroom by a CCD camera connected to a software-managed interface, making it possible to reconstitute the membrane as a synthesis image (Milliflex Rapid software v3.0).
  • the minimum ATP concentration measured is 200 attomoles, i.e. the equivalent of the quantity of ATP extracted from a yeast or from 100 bacteria.
  • the cells present on the PVDF membrane after the bioluminescence detection step described above at point 1.2 are taken up in a lysis buffer.
  • lysis buffers have been tested. These buffers have been formulated from one or more of the products sold by the company SIGMA, chosen from the following, at different concentrations: guanidium thiocyanate (Ref. 50980), guanidium hydrochloride (Ref. G9284), Tris EDTA buffer (Ref. 86377), Triton
  • the lysis protocol is as follows:
  • the Milliflex membrane is placed on a cassette (ref Millipore cat number MPRBLB100) in such a way as to form a sealed unit, inside which 1 to 1.5 ml of the lysis composition is injected, using a syringe. 2. The membrane is maintained in contact with the lysis composition for 1h at 55°C under gentle agitation at 10-12 rpm.
  • the cell lysate is recovered using the syringe.
  • the cells are treated in the absence of proteinase K with a lysis composition comprising:
  • the isopropyl alcohol is added to the cell lysate thus treated, volume for volume.
  • the mixture obtained is centrifuged for 30 min at 13200 rpm at
  • the other method according to the invention consists of using an ultrafiltration membrane fitted in a centrifuge tube.
  • This type of membrane is available under the trade name of Microcon ® filter (Millipore, ref. 42413).
  • the Microcon ® filter contains a regenerated cellulose membrane, the pores of which allow the passage of molecules of nominal molecular weight less than 100,000 Da (MWCO).
  • MWCO nominal molecular weight less than 100,000 Da
  • the consumable has a capacity of 500 ⁇ l.
  • the nucleic acid purification protocol is as follows:
  • the filter is vortexed for a few seconds
  • the filter is centrifuged for 3 minutes at 1 ,000 x g;
  • the nucleic acids are recovered in the aqueous solution present in the 1.5 ml tube.
  • the PCR amplifications were carried out using the Qiagen PCR kit (Ref. 201223), following the manufacturer's instructions.
  • the volumes of reagents used are shown in Table 2.
  • the sequence of the primers manufactured by Eurogentec is shown in Table 3, as well as their hybridization temperature.
  • Table 3 sequence of the primers and target of the primers.
  • the PCR conditions for Bact-F and Bact-R are as follows: (Universal detection for the bacteria)
  • PCR conditions for YM-F and YM-R are as follows:
  • PCR conditions for the specific common detection of E. coli, B. subtilis and S. epidermidis are as follows: - 1 cycle at 95°C for 05:00 minutes;
  • PCR products are analyzed on agarose gel by comparison with a known scale DNA ladder (Gel Pilot 1 Kb or 100 bp Plus Ladder, Qiagen, Ref. 239045).
  • a first approach consisted of using commercial kits such as those from Qiagen ® or Dynal ® for example. However, their use did not permit a sufficient quantity of nucleic acids to be purified from the microorganisms retained at the surface of the filtration membrane to enable amplification by PCR detectable on agarose gel (the number of cells contained in a micro-colony detectable by the Milliflex Rapid system corresponds to 100-1000 bacterial cells.)
  • a second approach consisted of using a lysis composition having as its formulation: - guanidine thiocyanate 4M,
  • PCR amplifications were of a variable intensity from one preparation to another, probably due to a loss of genetic material during the precipitation step.
  • this was a failure because the lysis composition perforated the cellulose membrane, due to a guanidium thiocyanate concentration which was apparently too high (4M).
  • a third approach consisted of preparing and testing a series of compositions comprising guanidium chloride (GHCI). Detergents have been added to some of these compositions (Tween, Triton, NLS) and EDTA. These compositions have twice been independently tested on cells of the bacterium E. coli (gram-negative).
  • the extractions of genomic DNA were carried out starting either from fresh cells originating from a diluted culture, or fresh cells originating from micro-colonies after filtration on a membrane, or micro- colonies filtered on a membrane then treated by bioluminescence according to the Milliflex ® method, i.e. dead cells. In all cases, the genomic DNA content in the cell lysates was purified on a Microcon ® cellulose membrane, then amplified by PCR, using so-called universal primers.
  • GHCI guanidium chloride
  • N-lauroyl-sarcosine (NLS) 1 % final
  • the amplification results are shown in the table in Figure 1.
  • the controls used for testing the inhibition effect of the lysis compositions on the PCR originate from samples into which pure bacterial DNA was introduced before purification on a membrane. These results indicate that only composition 7 made it possible to obtain satisfactory and reproducible results as regards the cells filtered on a membrane. This is verified for a number of cells comprised between 10 and 100 previously treated by bioluminescence or not, i.e. living or dead at the time of cell lysis. These experiments show the significant influence of the lysis composition on the effectiveness of the DNA purification on a membrane and its amplification by PCR.
  • the protocol for the extraction and detection of genomic DNA developed using lysis composition No. 7 described above was applied to different microorganisms: Moulds, Yeasts, gram+ and gram- Bacteria, in order to verify the specificity and universality of the method according to the invention.
  • PCRs using the specific internal primers of the following microorganisms: ⁇ . subtilis ATCC 6633, S. epidermidis ATCC 14990, and E. coli ATCC 25922 were carried out to verify the specificity of the detection, in particular when several types of cells are in a mixture.
  • a population of cells comprising these three bacterial species was thus prepared, then filtered on a membrane of the Milliflex Rapid ® system, enabling their detection by ATP bioluminescence.
  • the results of detection by ATP-bioluminescence for 3 different cell samples are shown in Figure 4A.
  • the cells were treated with a lysis composition according to the invention (composition N°7) and their genomic DNA purified on a cellulose membrane as described previously.
  • the results obtained by PCR with the universal primers and each pair of specific primers are shown in Figure 4B.
  • RNA contained in the nucleic acid preparations HPA method (Hybridization Protection Assay)
  • HPA method Hybridization Protection Assay
  • RNA ribosomal RNA
  • Gen-Probe ® 104574 Rev.C
  • This kit makes it possible to quantify the concentration of the ribosomal RNA of P. acnes available after cell lysis.
  • the presence of RNA allows a single-strand DNA, comprising molecules of acridine ester, to be protected during the hybridization phase.
  • Peroxide ions are then added and the reading is taken.
  • the peroxide ions react with the acridine ester molecules, causing photon emission.
  • the quantity of photons emitted is proportional to the quantity of RNA originally added.
  • the light emitted is measured using a luminometer and the results are given in relative light units.
  • Table 4 compares the results obtained for the preparation extracted using the lysis composition No. 7 according to the invention, the preparation obtained using the lysis composition supplied with the MTC-NI kit, and for the negative and positive controls supplied in the MTC-NI kit.
  • This technique consists, in a first step, of retro-transcribing the RNA molecules present in the sample, then in a second step, synthesizing the RNA fragments
  • the TMA technique was implemented using the reagents from the Milliprobe Pseudomonas aeruginosa detection kit (Millipore ref. GPPAE0100).
  • Figure 8 represents the real-time detection of the amplification products synthesized in the reaction medium for each of the nucleic acid preparations according to the invention (30 and 300 CFU).
  • nucleic acids corresponding to 30 CFU allows a satisfactory amplification almost equivalent to that corresponding to 300 CFU, demonstrating a very high level of effectiveness for extraction of the RNA of P. aeruginosa by the lysis composition No. 7.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention porte sur un procédé pour l'extraction et la détection d'acides nucléiques sur une membrane, rendant possible d'identifier les micro-organismes présents en faible concentration dans un milieu liquide ou gazeux. L'invention porte également sur une nouvelle composition de lyse comprenant du chlorure de guanidium et comprenant entre 0,1 et 1 % de N-lauroyl-sarcosine (NLS), rendant possible la mise en œuvre de ce procédé.
EP09703892A 2008-01-21 2009-01-19 Procédé pour l'extraction et la purification d'acides nucléiques sur une membrane Withdrawn EP2245157A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0850360A FR2926560A1 (fr) 2008-01-21 2008-01-21 Procede d'extraction et de purification d'acides nucleiques sur membrane
PCT/IB2009/000269 WO2009093142A1 (fr) 2008-01-21 2009-01-19 Procédé pour l'extraction et la purification d'acides nucléiques sur une membrane

Publications (1)

Publication Number Publication Date
EP2245157A1 true EP2245157A1 (fr) 2010-11-03

Family

ID=39619375

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09703892A Withdrawn EP2245157A1 (fr) 2008-01-21 2009-01-19 Procédé pour l'extraction et la purification d'acides nucléiques sur une membrane

Country Status (6)

Country Link
US (3) US20090226910A1 (fr)
EP (1) EP2245157A1 (fr)
JP (1) JP2011509669A (fr)
CN (1) CN101978058A (fr)
FR (1) FR2926560A1 (fr)
WO (1) WO2009093142A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098971A1 (fr) * 2008-03-04 2009-09-09 Nagravision S.A. Procédé de compensation d'afficheur d'un programme de diffusion pour sa présence au cours d'une partie de cette diffusion
DE102010043015B4 (de) * 2010-10-27 2019-12-19 Robert Bosch Gmbh Verfahren zur Konzentration von Probenbestandteilen und Amplifikation von Nukleinsäuren
ES2708561T3 (es) 2013-03-14 2019-04-10 Translate Bio Inc Métodos para la purificación de ARN mensajero
US9677981B2 (en) 2013-03-15 2017-06-13 3M Innovative Properties Company Sample concentrator and method of use
US9382591B2 (en) 2013-06-06 2016-07-05 Pall Corporation Compositions for detecting Alicyclobacillus microorganisms
ES2750661T3 (es) 2014-04-25 2020-03-26 Translate Bio Inc Métodos para la purificación de ARN mensajero
EP3370773B1 (fr) 2015-11-04 2022-01-05 Duke University Polythérapie constituée d'immunotoxines et d'un inhibiteur de point de contrôle
CN106607013B (zh) * 2016-12-27 2019-04-12 苏州海苗生物科技有限公司 一种纳米多向层析核酸提取介质及其制备方法
CN107096385A (zh) * 2017-06-09 2017-08-29 天津施特雷生物科技股份有限公司 一种细菌过滤设备
CN108342382B (zh) * 2018-01-30 2020-12-15 广东海大畜牧兽医研究院有限公司 一种核酸快速提取方法及其试剂盒
CN118421617A (zh) 2018-08-24 2024-08-02 川斯勒佰尔公司 用于纯化信使rna的方法
CN110724633A (zh) * 2019-11-11 2020-01-24 浙江汇泽医药科技有限公司 一种微量细胞核酸提取与扩增系统及工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5422241A (en) * 1991-07-03 1995-06-06 Ambion, Inc. Methods for the recovery of nucleic acids from reaction mixtures
DE69311944T2 (de) * 1992-04-01 1997-11-20 Nihon Millipore Kogyo K K Verfahren zur Bestimmung der Anzahl lebender Mikroorganismen
EP0723549B1 (fr) * 1993-08-30 2003-12-17 Promega Corporation Compositions et procede de purification d'acides nucleiques
US5712095A (en) * 1994-06-16 1998-01-27 Becton Dickinson And Company Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors
JP2001501089A (ja) * 1996-09-24 2001-01-30 バハマイア，アンドレアス Ｄｎａ構築物及びこれらのｄｎａ構築物を用いてタンパク質を生産するための方法
GB9709728D0 (en) * 1997-05-13 1997-07-02 Dynal As Single step method
EP1498492B1 (fr) * 2003-07-15 2011-11-02 Lukas Bestmann Appareil pour la preparation des echantillons
DE102005057334A1 (de) * 2005-11-28 2007-06-06 Aj Innuscreen Gmbh Verfahren zur Isolierung von Nukleinsäuren aus beliebigen Ausgangsmaterialien

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2009093142A1 *

Also Published As

Publication number Publication date
US20090226910A1 (en) 2009-09-10
FR2926560A1 (fr) 2009-07-24
WO2009093142A1 (fr) 2009-07-30
CN101978058A (zh) 2011-02-16
US20110065110A1 (en) 2011-03-17
JP2011509669A (ja) 2011-03-31
US20100305312A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
US20090226910A1 (en) Method for the extraction and purification of nucleic acids on a membrane
US7893251B2 (en) Methods for selective isolation of nucleic acids from microbial cells present in samples containing higher eukaryotic cells and/or tissues
US20190218595A1 (en) Selective lysis of cells
EP3719141B1 (fr) Procédé, solution de lyse et kit de déplétion sélective d'acides nucléiques d'animaux dans un échantillon
US7374881B2 (en) Method for collecting and using nuclear mRNA
JP2008054660A (ja) 核酸を単離するためのろ過装置
EP3194626B1 (fr) Procédés et dispositifs pour détecter et identifier des micro-organismes
JP2016192967A (ja) 血液試料の微生物特異的フィルタ・インサイチュ分析の方法
JP6728608B2 (ja) 核酸分析用のサンプル調製方法
US20240025929A1 (en) Methods and devices for ultrasensitive direct detection of microorganisms
US11618917B2 (en) Methods for microbial DNA analysis
US11319582B2 (en) Methods for microbial DNA analysis
US20210371940A1 (en) Process for identifying and quantifying nucleic acid sequences from live microorganisms
US9512474B2 (en) Molecular targets and methods for formulation screening and preservative efficacy testing
JP2012019723A (ja) 微生物の回収方法、及び微生物由来ｄｎａの精製方法
JP5599013B2 (ja) 血液検体からの微生物核酸の抽出方法
EP4365292A1 (fr) Aptamer pour la détection du micro-organisme bacillus subtilis
JP4083860B2 (ja) 呼吸沈渣からのマイコバクテリア及びマイコバクテリアｄｎａの効率的回収のためのアルコール−塩緩衝剤洗浄の使用
US20210380930A1 (en) Methods, apparatus and kits for bacterial cell lysis
WO2020094675A1 (fr) Procédés, appareil et kits de lyse de cellule bactérienne
JP2008092835A (ja) 核酸抽出方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100819

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20110407

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EMD MILLIPORE CORPORATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120508